Success Stories: An Indian Staff Scientist in Biotechnology Gets NIW Approval without RFE, Thanks to Our Team’s Work with the Case Preparation

Client’s Testimonial:

“Thank you, guys! The whole process was very streamlined and easy, and I was surprised it got approved this fast. Thank you again.”

On January 28^th, 2023, we received another EB-2 NIW (National Interest Waiver) approval for a Staff Scientist in the Field of Biotechnology (Approval Notice).

General Field: Biotechnology

Position at the Time of Case Filing: Staff Scientist

Country of Origin: India

State of Residence at the Time of Filing: New York

Approval Notice Date: January 28^th, 2023

Processing Time: 3 months, 16 days

Case Summary:

As an expert in the field of biotechnology, our NIW (National Interest Waiver) client’s proposed endeavor was to work on elucidating the genetic mechanisms underlying neurodegenerative diseases using his expertise in neurodegenerative disease and biochemistry, genetics, and molecular biology techniques. He wanted to identify new bio targets for the treatment of Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative conditions through his research.

So, while preparing his case for submission to the USCIS, we collected the following data for his petition:

His research advancing his proposed endeavor is of great importance because it provides unprecedented insight into models of the neuronal mechanisms underlying neuronal degeneration, the central phenomenon involved in diseases and disorders like dementia, which includes Alzheimer’s disease, the most common form of dementia. By elucidating these neuronal processes, he has illuminated the neuronal basis of this debilitating and often lethal class of syndromes.
His proposed endeavor also has broad implications for the United States, wherein the identification of new neurological targets for the treatment of major neurodegenerative diseases like Alzheimer’s disease and Parkinson’s disease is of major economic as well as medical importance.
He has repeatedly equipped researchers and drug makers with state-of-the-art insights and models of the genetic and molecular complexes underlying major neurological diseases and disorders and aging, which is imperative for identifying new neuron-level bio targets for the treatment of debilitating neurological conditions, including but not limited to Alzheimer’s disease, Parkinson’s disease, and other dementias.
Due to his knowledge and expertise in neurodegenerative disease and biochemistry, genetics, and molecular biology techniques, he has been regularly invited to conduct peer reviews for authoritative journals in the field.
His research has resulted in 6 peer-reviewed journal articles (3 of them first-authored and 1 of them co-first-authored) which have been cited a total of 27 times.
Finally, his work has been appreciated by recommenders who furnished him with letters appraising his work.

So, our team was certain that since along with these pieces of information, he has pursued research directly related to his proposed endeavor for 12 years, he would definitely get the approval. And that is exactly what happened 3 months and 16 days after filing. We are proud of having worked with him on the case and of having helped him get this approval.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.